All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-33947693

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	33947693	A2721G	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
2	33947693	A636T	S	S	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
3	33947693	G167T	S	S	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
4	33947693	T2666C	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
5	33947693	A1062G	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
6	33947693	A1383C	X	X	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
7	33947693	A2590T	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
8	33947693	A2699G	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
9	33947693	A2867C	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
10	33947693	A469T	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
11	33947693	A841C	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
12	33947693	A951G	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
13	33947693	C1230G	X	X	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
14	33947693	C2288A	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
15	33947693	C2583G	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
16	33947693	C2771T	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
17	33947693	C2875A	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
18	33947693	C3026T	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
19	33947693	C619T	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
20	33947693	G1229A	X	X	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
21	33947693	G2357T	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
22	33947693	G3210A	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
23	33947693	G957T	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
24	33947693	T1078G	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
25	33947693	T2290C	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
26	33947693	T2708G	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
27	33947693	T357C	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
28	33947693	A1726C	X	X	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
29	33947693	A2627T	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
30	33947693	A2633G	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
31	33947693	A940C	S	S	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
32	33947693	C1828A	X	X	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
33	33947693	G2771T	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
34	33947693	T753A	S	S	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
35	33947693	A1762T	BCP		Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
36	33947693	G1764A	BCP		Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
37	33947693	T1165C	P	P	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View
38	33947693	T1978C	C	C	Liver Cirrhosis Carcinoma, Hepatocellular	G R L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.